Sunday 18 October 2026
Export ADGM’s income statement to Excel — free account
Adagio Medical Holdings, Inc.
ADGM Healthcare Medical Devices
Adagio Medical Holdings, Inc.’s revenue for fiscal 2024 (year ended December 2024) was $602,000.00, up 100.7% from fiscal 2023. In the quarter to June 2026, revenue fell 33.5%, EPS fell 15.4%, free cash flow fell 12.9% and total debt rose 46.6%, each against the same quarter a year earlier. Insiders bought in the last twelve months.
0.10
0.00
0.00%
Follow ADGM
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
P/E ratio |
— | — | — | — |
+8 more quarters Free account |
EV/Sales |
— | — | — | — | |
EV/FCF |
— | — | — | — | |
Quick Ratio |
1.02 | 1.51 | 2.08 | 0.48 | |
Current Ratio |
1.41 | 1.85 | 2.44 | 0.84 | |
Net Debt/EBITDA |
(3.61) | (2.00) | (1.03) | (2.99) | |
Debt/Assets |
73.30% | 58.19% | 48.64% | 67.17% | |
Debt/Equity |
(59.85) | 4.00 | 1.70 | (16.15) | |
Asset Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF/Net income |
0.78 | 0.59 | 1.25 | 0.30 | |
Capex/Depreciation |
(0.03) | (0.01) | 2.07 | (2.72) | |
Interest Coverage |
(6.13) | (6.68) | (5.23) | (7.64) | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Intangible Assets out of Total Assets |
0.62 | 0.53 | 0.48 | 0.66 | |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Free Cash Flow Yield |
— | — | — | — | |
Revenue per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF per Share |
(0.24) | (0.19) | (0.25) | (0.20) | |
Capex per Share |
0.00 | 0.00 | 0.03 | (0.03) | |
Free Cash Flow per Share |
(0.24) | (0.19) | (0.22) | (0.23) | |
Cash per Share |
0.35 | 0.58 | 1.03 | 0.30 | |
Shareholders Equity per Share |
(0.02) | 0.26 | 0.75 | (0.09) | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
(0.02) | 0.26 | 0.75 | (0.09) | |
Free Cash Flow |
(5.27) | (4.13) | (3.65) | (3.53) | |
Working Capital |
3.13 | 7.28 | 11.85 | (1.56) | |
Capital Expenditures |
(0.01) | 0.00 | 0.49 | (0.52) | |
Net Current Asset Value |
(23.61) | (17.73) | (10.77) | (24.71) | |
EV/EBIT |
— | — | — | — | |
Capex to Sales |
0.00 | 0.00 | 0.00 | 0.00 | |
| Other line items | |||||
Average Payables |
1.01 | 1.93 | 1.96 | 2.72 | |
Average Inventory |
1.91 | 1.96 | 2.12 | 2.84 | |
Average Assets |
34.88 | 40.32 | 45.85 | 69.37 | |
Average Common Equity |
4.13 | 9.06 | 16.16 | 37.62 |
Columns are period end dates